Trials / Completed
CompletedNCT06289166
Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with Inhibitor
A Multi-center, Open-label, Phase Ⅱb Trial to Evaluate the Safety and Efficacy of STSP-0601 for Injection in Patients with Hemophilia with Inhibitor
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Staidson (Beijing) Biopharmaceuticals Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess the safety and efficacy of multiple-dose of STSP-0601 for the treatment of bleeding episodes in hemophilia A or B patients with inhibitor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | STSP-0601 for Injection | A Multiple-dose Design to Evaluate the Safety, Tolerability and Efficacy of STSP-0601 for Injection in hemophilia A or B patients with inhibitor. |
Timeline
- Start date
- 2024-03-18
- Primary completion
- 2024-10-17
- Completion
- 2024-10-17
- First posted
- 2024-03-01
- Last updated
- 2025-01-22
Locations
20 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06289166. Inclusion in this directory is not an endorsement.